A journey through the molecular networks of endomyocardial biopsies to explore ATTR and AL<i>λ</i> cardiac amyloidosis.

and ATTR conditions, respectively. These findings corroborate previously proposed pathological mechanisms, namely, direct mitochondrial toxicity of light chain fibrils internalized via macropinocytosis and massive extracellular deposition of ATTR. Notably, protein quantification and network topology enabled the identification of potential disease markers. Although the selection criteria were robust, validation in larger cohorts is needed. Nevertheless, given the challenging accessibility of the analyzed samples, the proposed landscape of results provides a valuable resource to encourage further studies on cardiac amyloidosis.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-07-17
DOI
https://doi.org/10.1016/j.isci.2026.116573
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A journey through the molecular networks of endomyocardial biopsies to explore ATTR and ALλ cardiac amyloidosis.

Francesca Brambilla, Joakim Sandstedt, Göran Larson, Kristina Vukušić et al.
PubMed
Amyloidosis: Diagnosis, Treatment, Outcomes
article

A journey through the molecular networks of endomyocardial biopsies to explore ATTR and ALλ cardiac amyloidosis.

Francesca Brambilla, Joakim Sandstedt, Göran Larson, Kristina Vukušić, Kristjan Karason, Saleh Hamed, Raffaello Viganò, Emanuele Bobbio, Fredrik Noborn, Anders Oldfors, Pierluigi Mauri, Andrea Lomagno, Dario Di Silvestre, Jonas Nilsson
article en

Abstract

and ATTR conditions, respectively. These findings corroborate previously proposed pathological mechanisms, namely, direct mitochondrial toxicity of light chain fibrils internalized via macropinocytosis and massive extracellular deposition of ATTR. Notably, protein quantification and network topology enabled the identification of potential disease markers. Although the selection criteria were robust, validation in larger cohorts is needed. Nevertheless, given the challenging accessibility of the analyzed samples, the proposed landscape of results provides a valuable resource to encourage further studies on cardiac amyloidosis.

PubMedVol. 29(7)
Sahlgrenska University Hospital (SE), Institute for Experimental Endocrinology and Oncology (IT), Institute of Biomedical Technologies (IT), University of Gothenburg (SE)
Openalex Percentile: Top 19%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.